Interestingly, serotonin 5-HT6 receptor (5-HT6R) antagonists, i.e., idalopirdine, intepirdine or latrepirdine (Figure 1), were an interesting group of compounds investigated for potential use in the treatment of AD. The gene discussed is HTR6; the disease is Alzheimer disease.